At this time, product has not yet been returned and a valid serial number has not been provided.An extended investigation has been performed for the reported complaint, and there was no indication that the product did not meet specification.Clinical data was reviewed and confirmed that libre sensors continue to be safe, effective, and perform as intended in the field.Stability data for libre sensors was reviewed and showed no anomalies or non-conformances that could have lead to the complaint.A tripped trend review was conducted for the reported complaint and freestyle libre sensors; no trends were identified that would indicate any product related issues.If the product is returned, a physical investigation will be performed and a follow-up report submitted.The device manufacturing date is unknown.The date entered in section h4 is the date abbott diabetes care became aware of the event.All pertinent information available to abbott diabetes care has been submitted.
|
Abbott diabetes care received a dkma declaration which reported the following information: it was reported via a healthcare facility a low readings issue with the adc device.It was reported that a customer had paused their slow-acting insulin, and a sensor reading of 9 mmol/l was obtained.The customer checked their blood glucose with a capillary meter and obtained a result of 19 mmol/l, as well as a ketone result of 4.7 mmol/l.The customer was hospitalized with diabetic ketoacidosis.No details regarding treatment were reported.The reporter was contacted; however, she was unable to provide further information regarding this event as the patient file could not be found without additional patient information.There was no report of death or permanent injury associated with this event.
|